Breaking News Instant updates and real-time market news.

RDY

Dr. Reddy's

$33.26

0.65 (1.99%)

06:18
10/15/18
10/15
06:18
10/15/18
06:18

Dr. Reddy's receives approval for aspirin and Dipyridamole capsules in U.S.

Dr. Reddy's received approval for Aspirin and Extended-Release Dipyridamole Capsules, a therapeutic equivalent generic version of Aggrenox Capsules in the U.S. market from the FDA. The company is working towards launching the product. The Aggrenox brand and generic had U.S. sales of approximately $183M MAT for the most recent twelve months ending in August. Aggrenox is a registered trademark of Boehringer Ingelheim.

  • 17

    Oct

  • 19

    Oct

RDY Dr. Reddy's
$33.26

0.65 (1.99%)

10/27/17
10/27/17
UPGRADE
Target $97

Equal Weight
Celgene upgraded to Equal Weight after expectations reset at Morgan Stanley
As previously reported, Morgan Stanley analyst Matthew Harrison upgraded Celgene to Equal Weight from Underweight, saying he believes expectations have been reset and the current price better reflects the clinical, commercial and generic risks the company faces. From here, he still sees the near-term risk related to Dr. Reddy's (RDY) and generics outweighing potential positive catalysts at the ECTRIMS and ASH meetings, Harrison tells investors, adding that the current level of the shares captures "some" of those risks. He lowered his price target on Celgene shares to $97 from $115.
03/27/18
EVER
03/27/18
NO CHANGE
Target $155
EVER
Outperform
Evercore sees higher chances of Revlimid patent settlement for Celgene
Evercore ISI analyst Umer Raffat believes the odds of a Revlimid patent settlement between Celgene (CELG) and Dr. Reddy's (RDY) have gone up "considerably" following a recent court filing. The filing, according to the analyst, shows Dr. Reddy's agreed to resolve claims construction issues, which he believes "implies a clear alignment in thought process between both sides." A potential settlement on Revlimid remains the biggest catalyst on Celgene in 2018, and could lead a quick re-rating in the valuation multiple, Raffat tells investors in a research note. He keeps Celgene as his top pick for 2018 with an Outperform rating and $155 price target.
05/29/18
RHCO
05/29/18
NO CHANGE
Target $96
RHCO
Hold
Celgene price target lowered to $96 from $106 at SunTrust
SunTrust analyst Yatin Suneja lowered his price target on Celgene (CELG) to $96 after last week's R&D meeting hosted by the management, which "highlighted" the importance of the multiple myeloma program to the company, its research into the mechanism of iMiD drugs, and its pursuit of anti-B-cell maturation antigen in treatment function. The analyst believes that while the company can sustain its position of leadership in myeloma, he is concerned with the overhang on the stock coming from intellectual property litigation on Revlimid, anticipating the stock to remain rangebound until next week's likely generic Revlimid settlement with Dr. Reddy's (RDY).

TODAY'S FREE FLY STORIES

SEDG

SolarEdge

$89.14

0.19 (0.21%)

, ISCA

International Speedway

$45.21

0.165 (0.37%)

17:22
10/14/19
10/14
17:22
10/14/19
17:22
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

SolarEdge Technologies…

SEDG

SolarEdge

$89.14

0.19 (0.21%)

ISCA

International Speedway

$45.21

0.165 (0.37%)

GLUU

Glu Mobile

$5.50

0.025 (0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 06

    Nov

  • 13

    Nov

  • 03

    Dec

GLUU

Glu Mobile

$5.50

0.025 (0.46%)

, SEDG

SolarEdge

$89.14

0.19 (0.21%)

17:18
10/14/19
10/14
17:18
10/14/19
17:18
Hot Stocks
Breaking Hot Stocks news story on Glu Mobile, SolarEdge »

Glu Mobile to replace…

GLUU

Glu Mobile

$5.50

0.025 (0.46%)

SEDG

SolarEdge

$89.14

0.19 (0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 13

    Nov

  • 03

    Dec

SEDG

SolarEdge

$89.14

0.19 (0.21%)

, ISCA

International Speedway

$45.21

0.165 (0.37%)

17:17
10/14/19
10/14
17:17
10/14/19
17:17
Hot Stocks
SolarEdge to replace International Speedway in S&P 400 at open on 10/18 »

Nascar Holdings is…

SEDG

SolarEdge

$89.14

0.19 (0.21%)

ISCA

International Speedway

$45.21

0.165 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 03

    Dec

SFIX

Stitch Fix

$21.21

-0.62 (-2.84%)

17:12
10/14/19
10/14
17:12
10/14/19
17:12
Initiation
Stitch Fix initiated  »

Stitch Fix initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

BLMN

Bloomin' Brands

$18.15

-0.83 (-4.37%)

17:12
10/14/19
10/14
17:12
10/14/19
17:12
Downgrade
Bloomin' Brands rating change  »

Bloomin' Brands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QIWI

Qiwi

$20.34

0.09 (0.44%)

17:02
10/14/19
10/14
17:02
10/14/19
17:02
Hot Stocks
Qiwi CFO Vladislav Poshmorga resigned effective October 8th »

QIWI plc announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RLMD

Relmada Therapeutics

$11.10

0.4 (3.74%)

16:51
10/14/19
10/14
16:51
10/14/19
16:51
Hot Stocks
Relmada Therapeutics to announces Phase 2 study results of REL-107 on October 15 »

Relmada Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGFS

AgroFresh Solutions

$2.39

0.125 (5.53%)

16:47
10/14/19
10/14
16:47
10/14/19
16:47
Hot Stocks
AgroFresh awarded $31M in damages in Decco Poast-Harvest lawsuit »

AgroFresh was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EHTH

eHealth

$53.12

-2.86 (-5.11%)

16:47
10/14/19
10/14
16:47
10/14/19
16:47
Initiation
eHealth initiated  »

eHealth initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

GPN

Global Payments

$164.14

1.2 (0.74%)

16:38
10/14/19
10/14
16:38
10/14/19
16:38
Initiation
Global Payments initiated  »

Global Payments initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 31

    Oct

  • 13

    Nov

APTS

Preferred Apartment

$14.41

0.075 (0.52%)

16:36
10/14/19
10/14
16:36
10/14/19
16:36
Hot Stocks
Preferred Apartment names Joel Murphy as CEO, effective January 1, 2020 »

Preferred Apartment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OHI

Omega Healthcare

$43.05

0.65 (1.53%)

16:36
10/14/19
10/14
16:36
10/14/19
16:36
Hot Stocks
Omega Healthcare raises quarterly dividend to 67c from 66c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

RPAY

Repay Holdings

$13.21

-0.07 (-0.53%)

16:35
10/14/19
10/14
16:35
10/14/19
16:35
Hot Stocks
Breaking Hot Stocks news story on Repay Holdings »

Repay Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 19

    Nov

SQ

Square

$61.83

0.29 (0.47%)

16:34
10/14/19
10/14
16:34
10/14/19
16:34
Initiation
Square initiated  »

Square initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 29

    Oct

  • 06

    Nov

FISV

Fiserv

$106.05

0.41 (0.39%)

, FDC

First Data

$0.00

(0.00%)

16:34
10/14/19
10/14
16:34
10/14/19
16:34
Initiation
Fiserv, First Data initiated  »

Fiserv initiated with a…

FISV

Fiserv

$106.05

0.41 (0.39%)

FDC

First Data

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 27

    Oct

LDOS

Leidos

$82.50

-0.66 (-0.79%)

16:31
10/14/19
10/14
16:31
10/14/19
16:31
Hot Stocks
Leidos awarded $926M TSA screening equipment contract »

Leidos was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 12

    Nov

RETA

Reata Pharmaceuticals

$100.37

4.57 (4.77%)

16:30
10/14/19
10/14
16:30
10/14/19
16:30
Hot Stocks
Breaking Hot Stocks news story on Reata Pharmaceuticals »

Reata Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
10/14/19
10/14
16:30
10/14/19
16:30
Options
Preliminary option volume of 13.7M today »

Preliminary option volume…

FIS

FIS

$132.70

0.69 (0.52%)

16:29
10/14/19
10/14
16:29
10/14/19
16:29
Initiation
FIS initiated  »

FIS initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 19

    Nov

AKRX

Akorn

$3.81

-0.105 (-2.69%)

16:28
10/14/19
10/14
16:28
10/14/19
16:28
Hot Stocks
Akorn gets FDA approval for Betamethasone Dipropionate Lotion, augmented »

Akorn announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

EHTH

eHealth

$53.12

-2.86 (-5.11%)

16:27
10/14/19
10/14
16:27
10/14/19
16:27
Initiation
eHealth initiated  »

eHealth initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

GPN

Global Payments

$164.14

1.2 (0.74%)

16:26
10/14/19
10/14
16:26
10/14/19
16:26
Initiation
Global Payments initiated  »

Global Payments initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 31

    Oct

  • 13

    Nov

SQ

Square

$61.83

0.29 (0.47%)

16:25
10/14/19
10/14
16:25
10/14/19
16:25
Initiation
Square initiated  »

Square initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 29

    Oct

  • 06

    Nov

FISV

Fiserv

$106.05

0.41 (0.39%)

16:24
10/14/19
10/14
16:24
10/14/19
16:24
Initiation
Fiserv initiated  »

Fiserv initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 27

    Oct

FICO

Fair Isaac

$310.44

0.46 (0.15%)

16:23
10/14/19
10/14
16:23
10/14/19
16:23
Initiation
Fair Isaac initiated  »

Fair Isaac initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.